RT Journal
A1 Gallagher TQ, Brigger MT, Hartnick CJ
T1 BLeeding risk and dexamethasone use in children undergoing tonsillectomy—reply
JF JAMA
JO JAMA
YR 2013
FD February 6
VO 309
IS 5
SP 437
OP 438
DO 10.1001/jama.2012.113521
UL http://dx.doi.org/10.1001/jama.2012.113521
AB 
In Reply: In noninferiority trials, the margin of noninferiority must be determined based on both statistical reasoning and clinical judgment.1 We think both criteria were satisfied in our study. The chief concern by Dr Czarnetzki and colleagues was that the same noninferiority threshold of 5% was applied to all bleeding end points and that this level was too high for level III bleeding. These concerns were at the center of our decision to choose level III bleeding rates as our primary end point and to power the study based on these rates and not on the comparison between the means of all types of bleeding events.